Caplyta receives additional FDA approval for new indication by end of 2025?

Will IDRX-42 receive FDA Fast Track designation by mid-2025?

Regulatory body blocks J&J acquisition of Intra-Cellular Therapies by end of 2025?

Company making largest biotech acquisition by end of 2025?

Johnson & Johnson completes acquisition of Intra-Cellular Therapies by June 30, 2025?

Next major biotech acquisition announcement by March 31, 2025?

Final acquisition price per share for Intra-Cellular Therapies?

What will be the outcome of IDRX-42 Phase 1 trial by the end of 2025?

Will GSK complete the acquisition of IDRx by March 31, 2025?

Will IDRX-42 receive FDA approval for GIST treatment by the end of 2025?

Will GSK announce significant advancements in IDRX-42 Phase 1 trial results by June 30, 2025?

What will be GSK's next strategic move in oncology by the end of 2025?

How many regulatory milestones will IDRx achieve by the end of 2025?

Will IDRX-42 enter Phase 2 clinical trials by the end of 2025?

Which area will GSK prioritize in its 2025 strategy?

What will be the growth in GSK's oncology portfolio revenue in 2025?

Which milestone will GSK's IDRX-42 achieve in 2025?

Will GSK report positive interim results for IDRX-42 in Phase 1 trials by Q3 2025?